首页/数据集/Neutralization against XBB.1 and XBB.1.5 after omicron subvariants breakthrough infection or reinfection

Neutralization against XBB.1 and XBB.1.5 after omicron subvariants breakthrough infection or reinfection

NCATS Open Data2023-10-12 更新2026-08-08 收录

新冠病毒中和抗体反应

病毒变种免疫逃逸

数据链接：

https://doi.org/10.1016/j.lanwpc.2023.100759 数据链接链接失效反馈

官方服务：

资源简介：

Neutralization against XBB.1 and XBB.1.5 after omicron subvariants breakthrough infection or reinfection

应用场景：

创建时间：

2023-04-04

中和抗体检测

病毒变种免疫逃逸

To investigate cross-neutralization of the B.1.1.7 and B.1.351 SARS-CoV-2 variants in a well-characterized cohort of early pandemic convalescent subjects

DataCite Commons2022-12-21 更新70

Replication Data for: COVID-19 vaccine booster dose fails to enhance immune response to Omicron variant in reinfected healthcare workers

免疫效果评估

病毒变种免疫逃逸

A prospective cohort study was designed to assess durability and level of humoral response of 678 healthcare workers fully vaccinated against COVID-19. They were categorized based on their primary vac

NIAID Data Ecosystem50

Quantification of the neutralization resistance of the Omicron variant of concern

新冠病毒中和抗性

病毒变种免疫逃逸

Quantification of the neutralization resistance of the Omicron variant of concern

NCATS Open Data2021-12-10 更新30

SARS-CoV-2 vaccine breakthrough infections by Omicron and Delta variants in healthcare workers

疫苗突破感染

病毒变种免疫逃逸

An observational prospective cohort study was conducted in vaccinated employees with acute SARS-CoV-2 infection between October 2021 and February 2022. Serological and molecular testing was performed

NIAID Data Ecosystem60

Neutralization against Omicron subvariants after BA.5/BF.7 breakthrough infection weakened as virus evolution and aging despite repeated prototype-based vaccination 1

新冠疫苗免疫评估

病毒变种免疫逃逸

Background: Omicron had swept the mainland China between December 2022 and January 2023, while SARS-CoV-2 still continued to evolve. To fully prepare for the next wave, it’s urgent to evaluate the hum

NIAID Data Ecosystem40

Neutralization against XBB.1 and XBB.1.5 after omicron subvariants breakthrough infection or reinfection

资源简介：

相关数据集